Dolores Di Vizio | Biochemistry | Best Researcher Award

Prof. Dr. Dolores Di Vizio | Biochemistry | Best Researcher Award

Professor at Cedars-Sinai Medical Center, United States

Dr. Dolores Di Vizio is a globally recognized physician-scientist whose research has significantly advanced the fields of cancer biology, extracellular vesicles (EVs), and translational oncology. She holds multiple academic positions at Cedars-Sinai Medical Center and plays a leading role in international scientific organizations. Dr. Di Vizio is best known for pioneering the discovery of large oncosomes, a novel type of extracellular vesicle implicated in cancer progression and metastasis.

Publication Profile 

Scopus

Educational Background 

  • M.D., University of Naples Federico II, Italy

  • Ph.D., University of Naples Federico II, Italy
    (with postdoctoral training at Harvard Medical School)

Professional Experience 

  • Professor, Departments of Surgery, Pathology & Laboratory Medicine, and Biomedical Sciences
    Cedars-Sinai Medical Center, Los Angeles, CA

  • Co-Director, Cancer Biology Program
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai

  • Visiting Faculty

    • Yonsei University, Korea

    • University of Calabria, Italy

    • IRCCS Regina Elena, Italy

  • Former Faculty,
    Harvard Medical School

  • Editorial and Leadership Roles

    • Deputy Editor, Journal of Extracellular Vesicles (JEV)

    • Editorial Boards: Oncotarget, Biomedicines, Frontiers in Oncology, and others

    • Chair/Organizer: Gordon Research Conferences, ISEV 2021 & 2023

    • Member: NIH TPM Study Section, DoD Prostate Cancer Program, ERC Review Panel

Research Interests 

  • Extracellular Vesicles (EVs) & Large Oncosomes:
    Discovery, molecular profiling, and diagnostic applications.

  • Cancer Metastasis & Progression:
    Mechanisms of tumor dissemination, especially in prostate cancer.

  • Molecular Oncology & Signal Transduction:
    Role of cytoskeletal remodeling and intercellular communication in cancer.

  • Translational Research:
    Development of EV-based diagnostics and therapeutic targets.

Awards and Honors 

  • Over $10 Million in Competitive Research Funding:

    • NIH R01 Grants

    • Department of Defense (DoD)

    • Avon Foundation

    • American Italian Cancer Foundation (AICF)

  • Chair/Co-chair of International Conferences:

    • Gordon Research Conference (2020)

    • ISEV 2021 & 2023

  • Invited Speaker:
    Over 70 national and international institutions, including Nature Webinars, Keystone Symposia, NIH, and AACR.

  • Mentorship Awards and Leadership in Education

    • Mentor for DoD and SPORE programs

    • Participant in NIH T32, R25, and CTSI training programs

Conclusion 

Dr. Dolores Di Vizio is an internationally respected expert in cancer biology and extracellular vesicle research. Her innovative discoveries, particularly in EV biology and cancer metastasis, have earned her global recognition and continuous research support. Her leadership in academic, clinical, and scientific communities, combined with a deep commitment to mentorship and collaboration, makes her one of the most impactful physician-scientists of her generation. She is an ideal candidate for high-level research honors and awards, with a career that exemplifies scientific innovation, translational impact, and educational excellence.

Publications 

  1. Title: Extracellular vesicle heterogeneity through the lens of multiomics
    Journal: Cell Reports Medicine
    Type: Article
    Year: 2025


  2. Title: Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic
    Type: Review
    Year: 2025


  3. Title: Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer
    Journal: Clinical Cancer Research
    Type: Article
    Year: 2025


  4. Title: A class of large cell-like extracellular vesicles: Extracellular vesicles
    Journal: Nature Cell Biology
    Type: Article
    Year: 2025
    Citations: 3


  5. Title: Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
    Type: Review
    Year: 2025
    Citations: 3


  6. Title: ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer
    Journal: Nucleic Acids Research
    Type: Article
    Year: 2024
    Citations: 11


  7. Title: Multiparametric Single-Vesicle Flow Cytometry Resolves Extracellular Vesicle Heterogeneity and Reveals Selective Regulation of Biogenesis and Cargo Distribution
    Journal: ACS Nano
    Type: Article
    Year: 2024
    Citations: 15


  8. Title: Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis
    Journal: Journal of Hepatology
    Type: Article 
    Year: 2024
    Citations: 7


  9. Title: Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
    Journal: Journal of Extracellular Vesicles
    Type: Article
    Year: 2024
    Citations: 1,465


  10. Title: International Society for Extracellular Vesicles workshop. QuantitatEVs: Multiscale analyses, from bulk to single extracellular vesicle
    Journal: Journal of Extracellular Biology
    Type: Article 
    Year: 2024


 

 

 

 

Celine FABRET | Biology | Best Researcher Award

Assist. Prof. Dr. Celine FABRET | Biology | Best Researcher Award

Lecturer at Paris-Saclay University, France

Dr. Céline Fabret is a Research Associate Professor at Paris-Saclay University, working at the Institut de Biologie Intégrative de la Cellule (I2BC). She holds a Ph.D. in Molecular Biology and Genetics from Université Aix-Marseille II and has extensive postdoctoral experience in both France and the United States. Her research focuses on translation termination, ribosome rescue mechanisms, prion biology, and gene regulation in bacteria and yeast. With a strong background in genetics and RNA biology, she has contributed to several international genome projects and has published in leading journals. Dr. Fabret is also an experienced educator and mentor, actively involved in training students and participating in academic governance.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Molecular Biology and Genetics, Université Aix-Marseille II, France (1996)

    • Doctoral research at CNRS Marseille, within the European-Japanese Bacillus subtilis genome project

  • Master’s in Molecular Biology, Université Aix-Marseille II, France

Professional Experience 💼

  • 2025–Present: Research Associate Professor, Paris-Saclay University, I2BC

  • 2011–Present: Faculty member, Paris-Saclay University (teaching microbiology, genetics, molecular biology, genomics)

  • 2001–2011: Lecturer, Sorbonne University (Pierre et Marie Curie Campus)

  • 1999–2001: Researcher in P. Noirot’s lab at INRA, Jouy-en-Josas – Genetic tools development and essential gene characterization

  • 1998–1999: Researcher in L. Jannière’s lab at INRA – High-frequency in vivo mutagenesis system in E. coli

  • 1996–1998: Postdoctoral Fellow, J.A. Hoch’s Lab, The Scripps Research Institute (La Jolla, USA) – Sporulation and two-component systems in Bacillus subtilis

  • 1991–1996: Doctoral researcher, CNRS Marseille – DNA sequencing and transcriptional analysis in B. subtilis

Research Interests 🔬

Dr. Fabret’s research bridges bacterial and eukaryotic translation, gene regulation, and RNA biology. Her focus includes:

  • Translation termination mechanisms in yeast and bacteria

  • Prion biology and its effect on stop codon recognition ([PSI+] phenotype)

  • Ribosome rescue and RNA quality control systems (RQC2, trans-translation)

  • Antibiotic response and translational reprogramming in Gram-negative bacteria

  • Functional genomics and essential gene analysis in Bacillus subtilis

  • Post-transcriptional modifications and their role in translational fidelity

She has supervised 2 PhD theses, 3 Master 2 (M2), and 16 Master 1 (M1) students, contributing to the training of the next generation of molecular biologists.

Awards and Honors🏆✨

  • Lead participant in multiple European research consortia on genome projects and enzyme engineering

  • Co-author of high-impact publications in Nature Cell Biology, Structure, Nucleic Acids Research, Molecular Microbiology

  • Elected member of the Consultative Commission of Biology Specialists and the Biology Department Council, Paris-Saclay University

  • Recognized for interdisciplinary collaboration with pharmaceutical companies (e.g., Aventis) and international institutions

Conclusion🌟

Dr. Céline Fabret has made sustained and meaningful contributions to molecular microbiology, translation biology, and bacterial physiology. Through a unique combination of genetic, biochemical, and functional genomics approaches, she has deepened our understanding of translation mechanisms and gene regulation across domains of life. As a researcher, educator, and mentor, she remains committed to advancing science and supporting young scientists in their careers.

Publications 📚

  1. 🧬 Fabret C, Giudice E, Chat S, Gillet R, Namy O (2025)
    RQC2 is a major player in peptide release from stalled ribosomes
    Structure, 31: S0969-2126(25)00105-4.


  2. 🦠 Fruchard L, Babosan A, Carvalho A, Lang M, Li B, Duchateau M, Giai Gianetto Q, Matondo M, Bonhomme F, Hatin I, Arbes H, Fabret C, et al. (2025)
    Aminoglycoside tolerance in Vibrio cholerae engages translational reprogramming
    (Accepted, journal not specified).


  3. 🧪 Fabret C, Namy O (2021)
    Translation efficiency of E. coli ribosomes with covalently linked subunits
    Nucleic Acids Research, 49(9): 5308–5318.


  4. 🔬 Malagnac*, Fabret* et al. (2013)
    A gene regulated by a -1 frameshift in Podospora anserina
    PLoS One, 8(9): e73772. (co-first authors)


  5. 🔎 Cosnier B, Kwapisz M, Hatin I, Namy O, Fabret C (2011)
    Translational readthrough of S. cerevisiae genes IMP3 and PDE2
    PLoS One, 6(4): e19500.


  6. 🧫 Desmolaize B, Fabret C, Graille M, van Tilbeurgh H, Brochier-Armanet C, Namy O (2011)
    23S rRNA modifications in Bacillus subtilis
    Nucleic Acids Research, 39(21): 9368–9375.


  7. 🧬 Fabret C, Malagnac F, Namy O (2011)
    tRNA-CAU modification enzyme and AUA codon recognition in Bacillus subtilis
    Molecular Microbiology, 80(4): 1062–1074.


  8. 💡 Blanchet S, Cornu D, Hatin I, Grosjean H, Bertin P, Namy O, Fabret C (2015)
    eRF1 interactions with stop codons and the ribosome
    Nucleic Acids Research, 43(6): 3298–3308.


  9. 🧠 Kabani M, Melki R, Fabret C (2011)
    Prion formation and the eRF3 protein in yeast
    Molecular Microbiology, 81(3): 640–658.


  10. 🔬 Tork S, Hatin I, Rousset JP, Fabret C (2004)
    5′ and 3′ context effects on stop codon recognition
    Nucleic Acids Research, 32(2): 415–421.